Influvac Tetra
Details for Influvac Tetra vaccine and its components.
Sponsor:
Mylan Health
Administration route:
Intramuscular injection, Subcutaneous injection
Vaccine group:
All people aged ≥3 years only
Registered for use in people aged ≥3 years.
Quadrivalent inactivated influenza vaccine
Each 0.5 mL monodose pre-filled syringe contains:
- 15 µg haemagglutinin of each of the 4 recommended influenza virus strains
- ≤100 ng ovalbumin
- ≤0.01 mg formaldehyde
- 0.02 mg cetrimonium bromide
- 1 mg sodium citrate
- 0.2 mg sucrose
- 1 ng gentamicin sulfate
May contain traces of:
- tylosine tartrate
- hydrocortisone
- polysorbate 80
For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.
Page history
Last updated:
13 April 2021
Last reviewed:
13 April 2021
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/influvac-tetra.